Clinical Trial Update: U96-CAR-T-Cells For R/R B-ALL [Phase 1]

View source ↗

Summary

This clinical trial update reports a Phase 1 study of U96-CAR-T-Cells for relapsed or refractory B-cell acute lymphoblastic leukemia and B-cell lymphoma, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• B-cell Lymphoma

Drugs mentioned

• U96-CAR-T-Cells

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Relapsed or Refractory B Cell Leukemia and Lymphoma | Phase 1 | Status: RECRUITING